APP and Alzheimer disease: APP and PSEN-1 double knockin mouse models demonstrate that a decrease of AMPAR efficacy is relevant to synaptic downscaling, an early onset phenomenon in AD, and AMPAR is crucial for long-term potentiation (LTP), critical for memory encoding as well as memory flexibility52.